Stocks Health care BDMD
NASDAQ · Health careBaird Medical Investment Holdings Ltd (BDMD)
Baird Medical Investment Holdings Ltd reported revenue of $22.5M in fiscal 2025, down 39.2% from a year earlier. It posted a net loss of $27.3M. In fiscal 2025 capital spending exceeded operating cash flow by $1.4M. At December 31, 2025 it held $178.3K in cash against $8.7M of debt. Its latest periodic report to the SEC is the annual report (foreign issuer, amended) (20-F/A) filed on July 27, 2026.
Key facts about Baird Medical Investment Holdings Ltd
- Net worth
- Baird Medical Investment Holdings Ltd has a market value (market cap) of $4.7M at the latest share price, and shareholders' equity of $31.4M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $22.5M (-39.2% year on year), with a net loss of $27.3M.
- Cash flow
- In fiscal 2025 operations used $1.3M of cash.
- Latest report
- The latest periodic report (annual report (foreign issuer, amended), 20-F/A) was filed with the SEC on July 27, 2026 and covers the period to December 31, 2025. Open on SEC EDGAR
What Baird Medical Investment Holdings Ltd does
Baird Medical Investment Holdings Ltd is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker BDMD.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $22.5M | -$27.3M | -$0.98 | -$1.4M |
| 2024 | $37M | $12.5M | $0.57 | -$9.2M |
| 2024 | $31.5M | $10.5M | $0.51 | -$3.7M |
| 2022 | $35.1M | $12.6M | $0.61 | -$5.4M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where BDMD ranks in Health care
Latest SEC filings
What Baird Medical Investment Holdings Ltd has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 1, 2026Passive stake (5% or more) SCHEDULE 13G
- September 30, 2026
- September 30, 2026
- September 3, 2026
- August 6, 2026Form POS AM filing POS AM
- August 6, 2026Form F-3/A filing F-3/A
- July 31, 2026Activist stake (5% or more) SCHEDULE 13D
- July 27, 2026Annual report (foreign issuer, amended) 20-F/A · period to December 31, 2025Revenue fell 39% to $22.5M versus the prior year; diluted EPS -$0.98 versus $0.57.
- May 22, 2026Form POS AM filing POS AM
- May 22, 2026Form F-3 filing F-3
Insider trades
What the people running Baird Medical Investment Holdings Ltd did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
Who owns BDMD
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Grand Fortune Capital (HK) Co Ltd13D, may seek influence with 2 related filers | 19.1% | July 31, 2026 |
| L1 Capital Global Opportunities Master Fund, Ltd.13G, passive | 9.99% | October 1, 2026 |
| Alta Partners LLC13G, passive | 5.1% | May 8, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 36 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| UBS Group AG | 106,883 | -9,176 |
| Two Sigma Investments, LP | 55,500 | +8,913 |
| Renaissance Technologies LLC | 55,371 | new |
| Citadel Advisors LLC | 54,895 | new |
| Jane Street Group, LLC | 31,574 | -7,842 |
| National Bank of Canada | 28,484 | +16,784 |
| Sculptor Capital LP | 700,000 | 0 |
| Clear Street Group Inc. | 775,488 | 0 |
| Aristeia Capital, L.L.C. | 570,992 | 0 |
| Calamos Advisors LLC | 500,000 | 0 |
| Geode Capital Management, LLC | 19,596 | -5,846 |
| Linden Advisors LP | 435,179 | 0 |
| Adage Capital Partners GP, L.L.C. | 375,000 | 0 |
| XTX Topco Ltd | 11,170 | new |
| Davidson Kempner Capital Management LP | 250,000 | 0 |
| Goldman Sachs Group Inc | 220,004 | 0 |
| Toronto Dominion Bank | 160,933 | 0 |
| Saba Capital Management, L.P. | 132,013 | 0 |
| D. E. Shaw & Co., Inc. | 150,000 | 0 |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 150,000 | 0 |
Insiders
Questions about BDMD
What does Baird Medical Investment Holdings Ltd do?
Baird Medical Investment Holdings Ltd is a company in the Health care sector, listed on NASDAQ as BDMD. Its shares trade on NASDAQ under the ticker BDMD.
What is Baird Medical Investment Holdings Ltd's net worth?
Baird Medical Investment Holdings Ltd has a market value (market cap) of $4.7M at the latest share price, and shareholders' equity of $31.4M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Baird Medical Investment Holdings Ltd profitable?
No. In fiscal 2025 it reported a net loss of $27.3M on revenue of $22.5M.
How much revenue does Baird Medical Investment Holdings Ltd make?
In fiscal 2025 Baird Medical Investment Holdings Ltd reported revenue of $22.5M. That is 39.2% less than a year earlier.
When did Baird Medical Investment Holdings Ltd last report?
Its most recent periodic report is the annual report (foreign issuer, amended) (20-F/A) filed on July 27, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the passive stake (5% or more) from October 1, 2026.
Similar companies
Compare BDMD with
Follow BDMD
Get an email when Baird Medical Investment Holdings Ltd files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Baird Medical Investment Holdings Ltd tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.